New MDCG guidance documents under the MDR and IVDR

The new fees will not come into effect until next June, so that the fees established on December 2022 remain still valid.

The new fees will not come into effect until next June, so that the fees established on December 2022 remain still valid.
January 20, 2023

Last January 12, 2023, the European Commission published the MDCG 2023-2 regarding the List of Standard Fees. This document defines the term standard fee and provides the template for Notifies Bodies to define the list of fees for conformity assessment activities in accordance with Article 50 of the MDR and Article 46 of the IVDR. This guide allows free access or consultation, enhances transparency, and compares the different fees that may exist between different Notified Bodies. Now, let’s wait for when the Notified Bodies will start using their new template, which must be written in the same language(s) as the Notified Body website.

Yesterday, January 19, 2023, in line with the MDCG 2023-2, the AEMPS informed on new Spanish legislative changes affecting their fees. The Spanish Law 38/2022 (December 27, 2022) introduced changes in the application of fees for medicines, medical devices, cosmetic products, personal care products, pharmaceutical laboratories, and distribution entities. However, the new fees will not come into effect until next June, so that the fees established on December 2022 remain still valid.

You can read more at the following links:

AEMPS tasas medicamentos

MDGC standard fees EU 

If you are interested in receiving one or several of these documents, please let us know and we will be happy to provide them.

For further information on this subject please contact us at: [email protected]

Search News & Events

  • Filter by category

Share

Related news and events

ETERNAL | 6th General Assembly meeting

The 6th General Assembly meeting of the ETERNAL project successfully wrapped up last week! Hosted by Universität für Bodenkultur Wien, the meeting featured valuable updates

NEWS | FAQs on the European Health Data Space

The EHDS Regulation has three main parts, each with different addressees:

Chapter II on primary use provides additional rights to patients and establishes the technical infrastructure necessary for their implementation.

Chapter III on Electronic Health Record (EHR) systems is addressed to manufacturers and other economic operators who make EHR systems available on the market.

Chapter IV on secondary use is addressed to health data holders and users.

EVENT | DIA Europe

DIA Europe 2025 will focus on sustainability, innovation and collaboration – three key pillars for shaping the future of healthcare. From the environmental impact of pharmaceuticals and of the drug development lifecycle to sustainable partnerships and sustainable healthcare systems, DIA Europe 2025 will be the prime opportunity to discuss how collaboration and innovation can support sustainability in healthcare and each stakeholder’s role in making it happen.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting